XYNOMIC PHARMACEUTICALS HOLDINGS, INC.

Xynomic Pharmaceuticals Holdings, Inc. (Nasdaq: XYN) is a blank check company that targeted the pharmaceutical and biopharmaceutical sector, with particular interest in oncology and other therapeutic areas. The company filed its 10-Q with the SEC on August 7, 2018, under accession number 0001213900-18-010363, reflecting activity consistent with its post-IPO search period. XYN focused on identifying acquisition targets with operations in China and globally, positioning itself within the cross-border healthcare deal space that attracted significant SPAC attention during that period. The vehicle pursued a business combination strategy anchored in pharmaceutical development and commercialization assets. Visit SpacDesk and sign up for full data, filing history, and deal-flow analytics on XYN and hundreds of other SPAC vehicles.